GC Therapeutics logo

GC Therapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

1

Funding Rounds

$65.0m

Money raised

Overview

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Funding series

Funding Series Analysis

The company GC Therapeutics has raised a total of $65m in funding over 1 rounds.

Key Insights:

  • GC Therapeutics September 2024 Series A Funding Round: $65m
GC Therapeutics logo
GC Therapeutics September 2024 Series A Funding Round $65m

Industries

GC Therapeutics is active in the following industries:
  • Technology
  • Biotechnology
  • Pharmaceutical industry